Literature DB >> 6415411

[Migraine prevention by a calcium channel blocker. Results of a double-blind study of flunarizine vs. pizotifen].

R Wörz, C Drillisch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6415411

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN： 0341-3098


× No keyword cloud information.
  4 in total

Review 1.  Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

2.  [Therapy for migraine-the current state of the art and perspectives.].

Authors:  D Soyka
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

3.  [Headache in children.].

Authors:  R Pothmann
Journal:  Schmerz       Date:  1990-03       Impact factor: 1.107

Review 4.  Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine.

Authors:  K E Andersson; E Vinge
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.